As of November 6, 2026, Medtronic plc has reported 2 leadership change filings to the SEC under Item 5.02 of Form 8-K, from May 18, 2026 to October 19, 2026 (Form 8-K, October 19, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like Medtronic plc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Medtronic plc reported changes in 2 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-05-18 to 2026-10-19. Every row below is cited to the filing it comes from, and this page adds each new change as Medtronic plc files it.
Also on the record for Medtronic plc
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| April 28, 2026 | Stake report, Schedule 13G, by Vanguard Capital Management | 7.51% of the class | 5%+ stakes | Source |
| March 27, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | — | 5%+ stakes | Source |
| December 3, 2025 | Stake report, Schedule 13G/A, by The Vanguard Group | 10.21% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs Medtronic plc now and the warning signs.
Free to see. No signup.
Keep reading
More on Medtronic plc and the records around it.
Companies that share a holder
- Vanguard Capital Management also filed stake reports on 1495 other companies: A10 Networks Inc (Oct 2026), Altisource Portfolio Solutions SA (Oct 2026), Alto Neuroscience Inc (Oct 2026)
- The Vanguard Group also filed stake reports on 2384 other companies: BellRing Brands, Inc. (Sep 2026), CAL-MAINE FOODS INC (Sep 2026), FTAI Aviation Ltd. (Sep 2026)
Watch Medtronic plc
Get an email when Medtronic plc files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Medtronic plc?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Medtronic plc: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Medtronic plc covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
5 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-10-19 | Reported | not named in the filing | 8-K, 2026-10-19 | ||
| 2026-05-18 | Reported | not named in the filing | 8-K, 2026-05-18 |
New leaders reset buying decisions — get the Full Report on Medtronic plc: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the senior executive at Medtronic plc, with the record behind each one.
Find candidates like senior executive at Medtronic plcEvery change, in the filing's words
Reported
On October 15, 2026, the Board of Directors (the "Board") of Medtronic plc (the "Company") approved the appointment of Michael Marinaro, Executive Vice President and President, Medical Surgical Portfolio, Americas, and Global Commercial Operations to the role of President, Medtronic, effective October 14, 2026.
- In this expanded role, Mr. Marinaro will continue with his current responsibilities, in addition to exercising oversight responsibility for the Company's Greater China operations, which will continue to be managed locally by Alex Gu, Senior Vice President and President, Greater China.
- Mr. Marinaro will continue to report to Geoffrey S. Martha, who will continue to serve as the Company's Chairman of the Board of Directors and Chief Executive Officer.
- In connection with Mr. Marinaro's appointment as President, Medtronic, the Compensation and Talent Committee (the "Committee") of the Board approved changes to his compensation, including an increase in Mr. Marinaro's annual base salary to $1,000,000 for all of fiscal year 2027.
- Mr. Marinaro's target annual incentive opportunity under the Medtronic Incentive Plan will continue to equal 100% of his annual base salary.
- In addition, the Committee approved supplemental fiscal year 2027 long-term incentive awards with an aggregate target value of approximately $3.25 million, consisting of (i) a performance share unit award with a target value of $1.625 million, (ii) a stock option award with a grant date value of $975,000 and (iii) a restricted stock unit award with a value of $650,000, each to be granted on November 2, 2026 pursuant to the Company's 2021 Medtronic plc Long-Term Incentive Plan (the "Plan").
Reported
On May 18, 2026, Medtronic plc ("Medtronic" or the "Company") announced that Brett Wall will be departing from his position as Executive Vice President and President, Neuroscience Portfolio, and that Dr. Kweli Thompson, currently Senior Vice President and President, Cardiac Rhythm Management, will be assuming the role of Executive Vice President and President, Neuroscience Portfolio, effective June 1, 2026.
- Mr. Wall will remain an employee of the Company until September 1, 2026, to assist with the transition.
- Mr. Wall is entitled to and will receive severance payments and benefits consistent with Medtronic's severance practices for executive officers as described in Medtronic's 2025 Proxy Statement filed with the Securities and Exchange Commission on August 25, 2025.
Tools for this story
Each opens in a new tab, filled in for Medtronic plc. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.